Skip to main content
TipRanks
Go Ultimate75% OFF

Sonoma Pharmaceuticals (O8Z) Income Statement

1 Followers

Sonoma Pharmaceuticals Income Statement

Last quarter (Q2 2027), Sonoma Pharmaceuticals's total revenue was $7.17M, an increase of 28.02% from the same quarter last year. In Q2, Sonoma Pharmaceuticals's net income was $-66.00K. See Sonoma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Mar 23Jun 22
$ 19.53M$ 14.29M$ 12.73M$ 13.27M$ 12.63M
$ 7.42M$ 5.46M$ 4.75M$ 4.48M$ 3.99M
$ 9.88M$ 9.18M$ 9.45M$ 9.05M$ 9.88M
Depreciation and Amortization$ 139.00K$ 138.00K$ 176.00K$ 125.00K$ 186.00K
$ -2.32M$ -2.77M$ -4.86M$ -5.06M$ -5.22M
$ -2.46M$ -3.71M$ -4.70M$ -4.57M$ -5.89M
$ -958.00K$ 803.00K$ -330.00K$ -614.00K$ 469.00K
$ -3.42M$ -2.91M$ -5.03M$ -5.18M$ -5.42M
$ -3.17M$ -3.46M$ -4.83M$ -5.15M$ -5.09M
Per Share Metrics
Basic EPS$ -1.89$ -2.79$ -5.32$ -15.18$ -19.17
Diluted EPS$ -1.89$ -2.79$ -5.32$ -15.18$ -19.17
Weighted Average Shares Outstanding1.68M1.24M909.00K339.40K265.30K
Weighted Average Shares Outstanding (Diluted)1.68M1.24M909.00K339.40K265.30K

Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

-20M020M40M-100 %0 %100 %200 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin